首页 › 基金 › Sands Capital Alternatives, LLC › ABOS

Sands Capital Alternatives, LLC 对 ABOS 的持仓历史

ACUMEN PHARMACEUTICALS INC · 医疗保健

Sands Capital Alternatives, LLC 在 Q3 2026 的 13F 申报中披露持有 ABOS(ACUMEN PHARMACEUTICALS INC)3,720,105 股,市值约 US$8.3M,约占其申报组合的 1.22%,在其申报持仓中市值排名第 15 位。 Sands Capital Alternatives, LLC 最近 13 个申报季度中有 13 个季度披露了 ABOS 持仓,最早可追溯至 Q3 2023。

最新持仓 (Q3 2026)3.72M 股
申报持仓市值$8.26M
组合权重1.22%
首次申报Q3 2023
最近变动持有
更新于2026-11-13

最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR

Sands Capital Alternatives, LLC 对 ABOS 的持仓演变

Sands Capital Alternatives, LLC 于 Q3 2023 首次披露 ABOS 持仓:3,417,075 股(约 US$14.2M)。 在 13 次申报中,Sands Capital Alternatives, LLC 1 次增持、0 次减持、11 次保持不变。 最近一期申报(Q3 2026)显示持股 3,720,105 股、市值约 US$8.3M。

逐季持仓明细

季度股数金额变化
Q3 2023 3.42M $14.18M 新进
Q4 2023 3.42M $13.12M 持有
Q1 2024 3.42M $13.84M 持有
Q2 2024 3.42M $8.27M 持有
Q3 2024 3.42M $8.47M 持有
Q4 2024 3.42M $5.88M 持有
Q1 2025 3.42M $3.76M 持有
Q2 2025 3.42M $3.96M 持有
Q3 2025 3.42M $5.84M 持有
Q4 2025 3.42M $7.21M 持有
Q1 2026 3.72M $8.78M 增持
Q2 2026 3.72M $9.93M 持有
Q3 2026 3.72M $8.26M 持有

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 ABOS 与 13F 数据

ABOS(ACUMEN PHARMACEUTICALS INC)属于医疗保健行业。我们追踪的基金中还有 27 只申报持有 ABOS,申报仓位最大的包括:RA CAPITAL MANAGEMENT, L.P. (US$56.1M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 ABOS 的基金

查看 ABOS 的全部基金持有人 →

常见问题

How long has Sands Capital Alternatives, LLC held ABOS?

Sands Capital Alternatives, LLC has disclosed ABOS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Sands Capital Alternatives, LLC's current position in ABOS?

As of Q3 2026, Sands Capital Alternatives, LLC holds 3.72M shares of ABOS (ACUMEN PHARMACEUTICALS INC), valued at $8.26M, representing 1.22% of its reported portfolio and ranking #15.

Has Sands Capital Alternatives, LLC been buying or selling ABOS?

In the latest 13F filing (Q3 2026), Sands Capital Alternatives, LLC held unchanged its position in ABOS.

Which other funds hold ABOS?

Other major institutional holders of ABOS include RA CAPITAL MANAGEMENT, L.P., among 27 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.